Advertisement

Kappa Opioid Receptors on Immune Cells as Studied by Fluorescent Ligands

  • Jean M. Bidlack
  • Diane M. P. Lawrence
  • Tracey A. Ignatowski
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 402)

Abstract

Despite both functional (1–4) and molecular biological (5–8) evidence for the presence of opioid receptors on lymphocytes, the search for opioid binding sites on leukocytes has been difficult. Opioid binding sites possessing all the characteristics of the classical brain opioid receptors had not been detected until the identification of the κ opioid receptor on the mouse Rl.l thymoma cell line (9,10). Possible reasons why opioid receptors have been difficult to detect on mixed cell populations from the immune system include: 1) opioid receptors may be expressed on only a small population of lymphocytes; 2) the expression of opioid receptors on lymphocyte changes during lymphocyte maturation; and 3) radioreceptor binding methodology is not sufficiently sensitive to detect opioid receptors present at a low density. While the R1.1 cell line was useful in establishing that a lymphocyte could express an opioid receptor, interest still lies in determining if lymphocytes from a mixed cell population, such as thymus and spleen, express opioid receptors. To address this question, we developed an indirect immunofluorescent method that is more sensitive than radioreceptor binding assays (11,12).

Keywords

Opioid Receptor Specific Label Kappa Opioid Receptor Mixed Cell Population Mouse Thymocyte 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wybran. J., Appetboom.T.. Famacy. J.-P. and Govaerts. A. Suggestive evidence for receptors for morphine and methionine-enkephalin on normal human blood ‘r lymphocytes. J. Lmmunol. 123: 1068–1070 (1979).Google Scholar
  2. 2.
    Sharp. B. M.. Keane. W. F.. Suh. H. J.. Gekker. G.. Tsukavama, D. and Peterson. P.K. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endoerinologr 117: 793–795 (1985).CrossRefGoogle Scholar
  3. 3.
    Taub. D. D., Eisenstein, T. K., Geller, E. B.. Adler. M. W. and Rogers. T. J. Immunomodulatory activity of It-and K-selective opioid agonists. Prot. Vail. Acad. Sei. USA 88: 360–364 (1991).CrossRefGoogle Scholar
  4. 4.
    Linner. K.M., Quist. ILE. and Sharp. B.M. Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation. J. lntmmmol. 154: 5049–5060 (1995).Google Scholar
  5. 5.
    Belkowski. S.M.. Zhu, J.M.. Liu-Chen. L.-Y.. Eisenstein. T.K.. Adler. M.W. and Rogers. T. J. Sequence of kappa-opioid receptor cDNA in the R1.1 thymoma cell line.J. V’euroinununol. 62: 113–117 (1995).Google Scholar
  6. 6.
    Chuang. L.F.. Chuang. T.K.. Killam. K.F., Jr., Chuang, A.I., Kung. II.. Yu. L. and Chuang. R.Y. Delta opioid receptor gene expression in lymphocytes. Bioehen,. Biophs. Res. Comma. 202: 1291–1299 (1994).CrossRefGoogle Scholar
  7. 7.
    Gaveriaux, C., Peluso, J.. Simonin. F., LaForet. J. and Kieffer. B. Identification of kappa-and delta-opioid receptor transcripts in immune cells. FEBS Lett. 369: 272–276 (1995).PubMedCrossRefGoogle Scholar
  8. 8.
    Sedqi. M., Roy, S.. Ramakrishnan, S., Fide. R. and Loh. II.11. (1995) Complementary DNA cloning of a 0-opioid receptor from rat peritoneal macrophages. Biochent. Biopin•s. Res. Comm. 209: 563–574. 1995.Google Scholar
  9. 9.
    Bidlack. J.M., Saripalli. L.D. and Lawrence. D.M.P. K-Opioid binding sites on a murine lymphoma cell line. liur., J. Plutrmaeol. 227: 257–265 (1992).Google Scholar
  10. 10.
    Lawrence. D.M.P. and Bidlack. J.M. The kappa opioid receptor expressed on the mouse RI.1 thymoma cell tine is coupled to adenylyl cyclase through a pertussis toxin-sensitive guanine nucleotide-binding protein. J. Pharnurcol. Exp. liter 266: 1678–1683 (1993).Google Scholar
  11. 11.
    Lawrence. D.M.P.. El-llamouly. W.. Archer. S.. Leary. I.F. and Bidlack. J.M. Identification of n opioid receptors in the immune system by indirect immunofluorescence. Prow. Natl. Acad. Sei. U.S.A. 92: 1062–1066 (1995).CrossRefGoogle Scholar
  12. 12.
    Lawrence. D.M.R. Hutchison. 1.. Sexed-Mcvaffu’i.;\..Archer. S. and 13idlack..1.M. Improved fluorescent staining of kappa opioid receptors in the immune system using naltrexamine derivatives and phycocrythrin. Submitted.Google Scholar
  13. 13.
    Mathies. R.A. and Strver. L. Simile-Molecule Fluorescence Detection: A Feasibility Study Using Ph_vcoerythrin. in.Lpplirarinns of Fluorescence in llrc Bion ecliral Sciences (D.I. Taylor. A.S. Waggoner. R.F. Murphy. F. Lanni and R.R. Birge. ed.). Alan R. Liss. NY. pp. 129–140 (1986).Google Scholar
  14. 14.
    Lawrence. D.M.P.. Joseph. D.B. and Bidlack. J.M. Kappa opioid receptors expressed on three related thvmoma cell lines: differences in receptor-effector coupling. Biorhein. Pharinacol. 49:81–90 (1995).Google Scholar
  15. 15.
    Portoahese. P.S.. Lipkowski. A.W. and Takemori. A.E. Itinaltorphiminc and nor-binaltorphimine. potent and selective tc-opioid receptor antagonists. Lifi. Sci. 40: 128–1292 (1987).Google Scholar
  16. 16.
    Chao. C.C.. Dekker. G.. Hu. S.. Sheng. W.S. Bu. D.-I.. Archer. S.. Bidlack..J.M.. and Peterson. P.K. Kappa opioid receptors in human microelia downregulate human immunodeficiency virus-1 expression. Submitted.Google Scholar
  17. 17.
    Tang. M.F. Jourd Heuil. D.. Meddings. J.B. and Swain. M.G. Increased opioid binding to peripheral white blood cells in a rat model of acute cholestasis. Gacrrocuterohcnt 108: 1479–1486 (1995).Google Scholar
  18. 18.
    Auhin. I.F. Autolluore.scence of viable cultured nuarunaliart cells. J. llixrochenr. Cvtichem. 27: 36–13 (1979).Google Scholar
  19. 19.
    Oi. V.T.. Glazer. A.N. and Stryer. I.. Fluorescent phycobiliprotein conjugates for analyses of cells and molecules.J.Cell Biol. 93:981–086 (1982)Google Scholar
  20. 20.
    Chuang. L.-F.. Chuang. T.K.. Killen. K.F. Jr.. Oiu. Q.. Wang. X.R.. Lin. J.-J.. Kung. II.-I.. Sheng. W.. Chao. C.. Yu. I.. and Chuang. R.Y. Expression of kappa opioid receptors in human and monkey lymphocytes. Bioc-hein. Biopin’c. Reg. Commrmn. 209: 1003–101 (1995).Google Scholar
  21. 21.
    Chuang. T.K.. Kilian. K.F. Jr. Chuang. I.I.. Kung. I.-I.. Sheng. W.S.. Chao. C.C.. Yu. I.. and Chung. R.Y. Mu opioid receptor gene expression in immune cells. Bioc-hein. Biopin’c. Reg. Commrmn. 216: 922–9. 10 (1995).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1996

Authors and Affiliations

  • Jean M. Bidlack
    • 1
  • Diane M. P. Lawrence
    • 1
  • Tracey A. Ignatowski
    • 1
  1. 1.Department of Pharmacology and PhysiologyUniversity of Rochester, School of Medicine and DentistryRochesterUSA

Personalised recommendations